Thursday, Sep 28, 2023
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Education Today
    • Reviews
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Health | Astrazeneca Says Us Trial Data Shows Vaccine 79 Effective

AstraZeneca says US trial data shows vaccine 79% effective

Investigators said the vaccine was effective across all ages, including older people — which previous studies in other countries had failed to establish.

By AP
Updated On - 03:20 PM, Mon - 22 March 21
AstraZeneca says US trial data shows vaccine 79% effective
whatsapp facebook twitter telegram

London: AstraZeneca says advanced trial data from a U.S. study on its COVID-19 vaccine shows it is 79 per cent effective.

Although AstraZeneca’s vaccine has been authorised in more than 50 countries, it has not yet been given the green light in the US. The US study comprised 30,000 volunteers, 20,000 of whom were given the vaccine while the rest got dummy shots. The results were announced on Monday.

In a statement, AstraZeneca said its COVID-19 vaccine had a 79 per cent efficacy rate at preventing symptomatic COVID and was 100 per cent effective in stopping severe disease and hospitalisation. Investigators said the vaccine was effective across all ages, including older people — which previous studies in other countries had failed to establish.

The early findings from the US study are just one set of information AstraZeneca must submit to the Food and Drug Administration. An FDA advisory committee will publicly debate the evidence behind the shots before the agency decides whether to allow emergency use of the vaccine.

Scientists have been awaiting results of the US study in hopes it will clear up some of the confusion about just how well the shots really work.

Britain first authorised the vaccine based on partial results from testing in the United Kingdom, Brazil and South Africa that suggested the shots were about 70 per cent effective. But those results were clouded by a manufacturing mistake that led some participants to get just a half dose in their first shot — an error the researchers didn’t immediately acknowledge.

Then came more questions, about how well the vaccine protected older adults and how long to wait before the second dose. Some European countries including Germany, France and Belgium initially withheld the shot from older adults and only reversed their decisions after new data suggested it is offering seniors protection.

Last week, more than a dozen countries, mostly in Europe, temporarily suspended their use of the AstraZeneca shot after reports it was linked to blood clots. On Thursday, the European Medicines Agency concluded after an investigation that the vaccine did not raise the overall risk of blood clots, but could not rule out that it was connected to two very rare types of clots.

France, Germany, Italy and other countries subsequently resumed their use of the shot on Friday, with senior politicians rolling up their sleeves to show the vaccine was safe.

Also read:

It has tremendous potential: WHO on AstraZeneca jab


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


Telangana Today Whatsapp
  • Follow Us :
  • Tags
  • AstraZeneca
  • AstraZeneca Covid-19 vaccine
  • AstraZeneca vaccine
  • Coronavirus Vaccine

Related News

  • Wife’s efforts to meet expenses no ground to reduce maintenance amount by husband: Delhi HC

    Wife’s efforts to meet expenses no ground to reduce maintenance amount by husband: Delhi HC

  • China propels Apple’s growth in last 9 years, net sales up by 128%: Report

    China propels Apple’s growth in last 9 years, net sales up by 128%: Report

  • Memorial for journalists killed during COVID-19 to be inaugurated on October 2

    Memorial for journalists killed during COVID-19 to be inaugurated on October 2

  • India records 40 fresh Covid-19 cases on Monday

    India records 40 fresh Covid-19 cases on Monday

  • India reports 70 new Covid-19 cases

    India reports 70 new Covid-19 cases

  • Opinion: Why slowing China worries West

    Opinion: Why slowing China worries West

Latest News

  • US Embassy in India surpasses goal of processing one million non-immigrant visas

    1 min ago
  • Hyderabad: Pakistan Captain Babar Azam touched by Indian fans’ support for World Cup 2023

    6 mins ago
  • Bihar: Nitish angered by English display board at school library

    8 mins ago
  • Joe Jonas, Sophie Turner debate over divorce proceedings location

    16 mins ago
  • BJP central leadership in hectic parleys with AIADMK through mediators

    23 mins ago
  • Delhi Police register case for Pro-Khalistani graffiti under Kashmiri gate flyover

    26 mins ago
  • Indian-American presidential aspirant Vivek Ramaswamy attacked by rivals over Ukraine

    34 mins ago
  • US Secretary of State Antony Blinken launches Global Music Diplomacy Initiative

    37 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam